Incidence of melanoma is not elevated in patients with Graves' disease: A retrospective, matched-cohort study
JAAD Int
.
2023 Mar 29:11:222-223.
doi: 10.1016/j.jdin.2023.03.001.
eCollection 2023 Jun.
Authors
Neha Nitisha Deo
1
,
Elliott Harrison Campbell
2
,
Ben Gorman
1
3
,
Barbara Mullen
1
,
Jiwon Ahn
4
,
Sama Carley
5
,
Regina Castro
6
,
Austin Todd
7
,
Nahid Y Vidal
2
Affiliations
1
Mayo Clinic Alix School of Medicine, Rochester, Minnesota.
2
Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
3
Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
4
Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
5
Sharp Rees-Stealy Medical Group, Dermatology, San Diego, California.
6
Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.
7
Clinical Trials and Biostatistics Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
PMID:
37152216
PMCID:
PMC10154956
DOI:
10.1016/j.jdin.2023.03.001
No abstract available
Keywords:
Graves; Graves disease; autoimmune; nonmelanoma skin cancer; skin cancer incidence.